EUR 1290.63 For Business Accounts Only

Generics Global Group of Eight (G8) Industry Guide 2013-2022

Generics Global Group of Eight (G8) Industry Guide 2013-2022

Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Questions Answered:

- What was the size of the G8 generics market by value in 2017?
- What will be the size of the G8 generics market in 2022?
- What factors are affecting the strength of competition in the G8 generics market?
- How has the market performed over the last five years?
- How large is the G8 generics market in relation to its regional counterparts?

Scope

Essential resource for top-line data and analysis covering the G8 generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

- The G8 countries contributed $1,75,638.2 million in 2017 to the global generics industry, with a compound annual growth rate (CAGR) of 7.3% between 2013 and 2017. The G8 countries are expected to reach a value of $2,25,943.9 million in 2022, with a CAGR of 5.2% over the 2017-22 period.
- Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $1,02,919.9 million in 2017. This was followed by Japan and Germany, with a value of $25,218.0 and $17,343.3 million, respectively.
- The US is expected to lead the generics industry in the G8 nations with a value of $1,30,127.0 million in 2016, followed by Japan and Germany with expected values of $33,841.0 and $19,577.2 million, respectively.

Reasons to buy

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market
- Leading company profiles reveal details of key generics market players’ G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country